Found 9 results
Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is C and Author is Gore-Langton, RE  [Clear All Filters]
Journal Article
H. X. Chen, Gore-Langton, R. E., and Cheson, B. D., Clinical trails referral resource. Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab, Oncology, vol. 15, pp. 1026-36, 2001.
J. B. Black, Feigal, E. G., and Gore-Langton, R. E., Clinical trials referral resource. Clinical trials and NCI resources for cancer in HIV+ patients, Oncology, vol. 16, pp. 200-2205 207, 2002.
L. E. Via, Gore-Langton, R. E., and Pluda, J. M., Clinical trials referral resource. Current clinical trials administering the antiangiogenesis agent SU5416, Oncology, vol. 14, pp. 13121315-16 1321-23, 2000.
J. Wright, Hillsamer, V. L., Gore-Langton, R. E., and Cheson, B. D., Clinical Trials Referral Resource. Current Clinical Trials for the Proteasome Inhibitor PS-341, Oncology, vol. 14, no. 11, pp. 1589-15901593-941597, 2000.
R. S. Kaplan, Gore-Langton, R. E., and Cheson, B. D., Clinical trials referral resource. Current clinical trials in prostate cancer, Oncology, vol. 14, pp. 399-400403-404, 2000.
E. L. Trimble, Rowland, J., Varricchio, C., and Gore-Langton, R. E., Clinical trials referral resource. Health-related quality of life in cancer clinical trials (Part I), Oncology, vol. 15, pp. 456-861-6, 2001.
E. L. Trimble, Rowland, J., Varricchio, C., and Gore-Langton, R. E., Clinical trials referral resource. Health-related quality of life in cancer clinical trials (Part II), Oncology, vol. 15, pp. 601-3606-8 611, 2001.
T. Davis, Gore-Langton, R. E., and Cheson, B. D., Clinical trials referral source. Current clinical trials of the anti- CD20 monoclonal antibody rituximab, Oncology, vol. 14, pp. 14371440-1443, 2000.
B. A. Conley, Gore-Langton, R. E., and Cheson, B. D., Clinical trials resource. Treatment of advanced or recurrent squamous cell carcinoma of the head and neck, Oncology, vol. 14, pp. 553-554559 561, 2000.